News that Haifa, Israel-based Pluristem Therapeutics (PSTI) has seen some success treating COVID-19 patients with “PLacental eXpanded” (PLX) cells sparked a 9.5% stock rally on Wall Street Thursday, and prompted
News that Haifa, Israel-based Pluristem Therapeutics (PSTI) has seen some success treating COVID-19 patients with “PLacental eXpanded” (PLX) cells sparked a 9.5% stock rally on Wall Street Thursday, and prompted
Given the troubling state of the U.S. economy, what’s driving the bullish sentiment on Wall Street? Stimulus. Among the bulls is chief investment strategist at CFRA, Sam Stovall, who estimates
It has been almost three months since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both the green and the red. Yet, since
Many biotechs have been on hot streaks in 2020, particularly those with the coronavirus on their agenda, as valuations have shot up on the back of urgently needed solutions for
Six months ago, disturbing liver biopsies suggesting some patients in an FDA Phase 2b study of CymaBay Therapeutics (CBAY) suffered inflamed and destroyed liver cells forced the company to suspend